Business Context and Reporting Period
This Form 8-K, dated August 2, 2017, reports on Tronox Limited (an Australian public limited company) and its U.S. subsidiaries. The filing details the entry into a material definitive agreement to sell the Company's Alkali business. This divestiture is part of a broader strategic plan to fund the pending acquisition of the titanium dioxide business of The National Titanium Dioxide Company, Ltd. (Cristal).
Key Financial Metrics and Transaction Terms
- Transaction Value: $1.325 billion in cash, subject to a working capital adjustment.
- Buyer: Genesis Energy, L.P.
- Asset Sold: The Alkali business (operated by Tronox Alkali Corporation).
- Expected Closing: Second half of 2017.
- Financing: The Purchaser is required to use commercially reasonable efforts to obtain debt and equity financing; however, there is no financing condition to the Transaction.
- Financial Statements: This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics for the Company or the Alkali business.
Material Changes and Conditions
The primary material change is the execution of the Stock Purchase Agreement. The completion of the transaction is subject to customary closing conditions, including:
- Expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
- Absence of any legal order or ruling prohibiting the transaction.
- Accuracy of representations and warranties and compliance with covenants by both parties.
- Obtaining necessary governmental consents and authorizations.
The agreement includes a termination right if the transaction has not closed by December 31, 2017.
Outlook, Risks, and Management Commentary
Management views this transaction as a strategic step to facilitate the Cristal acquisition. The Company has agreed to guarantee the indemnification and performance obligations of Tronox Holdings under the Purchase Agreement. Post-closing, the parties will enter into a transition services agreement and a non-compete agreement for three years.
Key Risks Identified:
- Failure of the transaction to close due to unmet conditions or termination.
- Need to seek alternative financing for the Cristal Transaction if this sale fails.
- Regulatory delays or conditions affecting the Cristal Transaction.
- Failure to realize expected synergies or manage the transaction efficiently.
- Market conditions, including interest rate increases and reduced customer demand.
Investor Verification Checklist
- Verify the status of the Hart-Scott-Rodino antitrust review and any required regulatory approvals.
- Confirm the progress of the separate Cristal Transaction and its financing requirements.
- Review the preliminary proxy statement filed on June 30, 2017, for details on the Cristal acquisition.
- Monitor the December 31, 2017, deadline for the Alkali business sale closing.
- Assess the impact of the working capital adjustment on the final purchase price.